Locations:
Search IconSearch
January 18, 2021/Neurosciences/Podcast

Early Adopter of Mobile Stroke Care Shares Operational Insights (Podcast)

Learnings on cost-effectiveness, working with municipalities and more

“Even 15 minutes can be the difference in a patient’s ability to walk after a stroke,” says Andrew Russman, DO, Medical Director of the Comprehensive Stroke Center and Mobile Stroke Treatment Unit in Cleveland Clinic’s Cerebrovascular Center. “And the time savings significantly reduces hospital mortality after acute ischemic stroke.”

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Cleveland Clinic’s mobile stroke unit was one of the first in the U.S., launched in 2014. As an early adopter, Dr. Russman shares insights on mobile stroke care in the newest episode of Cleveland Clinic’s Neuro Pathways podcast. Topics he discusses include:

  • Collaborating with municipalities and identifying a mobile stroke unit’s coverage area
  • Cost effectiveness of providing a mobile stroke unit
  • How patients with intracerebral hemorrhage are managed on the mobile unit

Click the podcast player above to listen to the episode now, or read on for a short edited excerpt. Check out more Neuro Pathways episodes at clevelandclinic.org/neuropodcast or wherever you get your podcasts.

Excerpt from the podcast

Dr. Russman: The Mobile Stroke Treatment Unit has a dedicated team that includes a critical care nurse, paramedic, emergency medical technician, CT technologist and, through a two-way audio-visual connection, a vascular neurologist. This team is essential to the operation of the unit, and it works with local emergency medical services (EMS) and the local EMS dispatch system.

When a patient calls 911, the dispatcher identifies that the patient is having stroke symptoms. Then they dispatch both the Mobile Stroke Treatment Unit and the local EMS unit to the patient’s location. The first responders (the local EMS unit) go into the home, identify the patient and the stroke symptoms, and then wave in members of the mobile stroke unit waiting at the patient’s doorstep. At that point, the patient is taken from the home and loaded onto the mobile stroke unit.

Advertisement

The first thing we do is work on getting IV access. We also obtain a noncontrast CT scan of the brain and complete a neurologic assessment using the National Institutes of Health Stroke Scale. A clinical decision is made after viewing the CT imaging, seeing the clinical exam and determining whether the patient is a candidate for thrombolysis (with IV tissue plasminogen activator) or has a potential large-vessel occlusion.

Our plan is to take the patient to a facility within their existing system of care, but it needs to be a hospital with the right capability. Patients with large blood vessel occlusions are taken to facilities able to perform endovascular therapy and retrieve the clot.

A lot of collaboration is involved. We work with local EMS and fire departments. We work with teams in emergency departments, and we work together within our own team to optimize these processes, share information with our partners and continue to improve our performance to provide the best clinical outcome for patients.

Advertisement

Related Articles

portrait of Dr. Kriti Bhayana against decorative background with podcast overlay
April 2, 2026/Neurosciences/Podcast

Practice Essentials for Pediatric and Perinatal Stroke (Podcast)

Types and presentation may differ from adults, but early recognition and intervention are just as key

Two-dimensional scatter plot of peak T1 versus T2 times from pre-extended lumbar drainage MRI

MR Fingerprinting Predicts Shunt Efficacy in NPH

Study tests potential for a more accurate treatment predictor

person going into a Gamma Knife machine for radiotherapy
March 25, 2026/Neurosciences/Brain Tumor

Predicting Response to Stereotactic Radiosurgery for Recurrent Glioblastoma

Study uses molecular and clinical stratification to help guide patient selection

illustration of human brain with rumor at top right
March 23, 2026/Neurosciences/Brain Tumor

Adding Eflornithine to Lomustine Extends Survival in Recurrent IDH-Mutant Grade 3 Astrocytoma

Phase 3 STELLAR trial underscores role of molecular stratification in glioma care

brain MRI taken from the back of the head
March 20, 2026/Neurosciences/Epilepsy

Unmasking the ‘Tethered’ Temporal Lobe: New MRI Metrics Improve Detection of Encephaloceles in Refractory Epilepsy

Early identification of temporal encephaloceles can improve surgical decision-making

brain scan with white lesion on right side

ARISE II Recommendations Chart a Course for Advancing Intracranial Hemorrhage Care

Academia, industry and government leaders develop consensus priorities

two brain scans side by side with a yellow circle on the left scan
March 13, 2026/Neurosciences/Epilepsy

SEEG Linked With More Complete Resection and Greater Seizure Freedom in MOGHE Subtype of Epilepsy

Insights from one of the first studies of invasive monitoring in the rare form of focal cortical dysplasia

histopathology image with pink background and arrow pointing to round cell

New Insights on α-Synuclein Pathology and Clinical Phenotypes in Dementia With Lewy Bodies

The disease’s neuropathologic heterogeneity holds clues to refining diagnosis and prognosis

Ad